THCA-A (CRM)

CAS No. 23978-85-0

THCA-A (CRM)( —— )

Catalog No. M23103 CAS No. 23978-85-0

THCA-A (CRM) is a certified reference material categorized as a phytocannabinoid.1 THCA-A is a common component of hashish but is non-psychoactive until heated via smoking, which converts it to Δ9-THC.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    THCA-A (CRM)
  • Note
    Research use only, not for human use.
  • Brief Description
    THCA-A (CRM) is a certified reference material categorized as a phytocannabinoid.1 THCA-A is a common component of hashish but is non-psychoactive until heated via smoking, which converts it to Δ9-THC.
  • Description
    THCA-A (CRM) is a certified reference material categorized as a phytocannabinoid.1 THCA-A is a common component of hashish but is non-psychoactive until heated via smoking, which converts it to Δ9-THC. THCA-A is regulated as a Schedule I compound in the United States. THCA-A (CRM) (Item No. ISO60175) is provided as a DEA exempt preparation. This product is intended for research and forensic applications.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    23978-85-0
  • Formula Weight
    358.5
  • Molecular Formula
    C22H30O4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    [H][C@]12C3=C(C=C(CCCCC)C(C(O)=O)=C3O)OC(C)(C)[C@]1([H])CCC(C)=C2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Anisatin

    Anisatin, a toxic, insecticidally active component of Sikimi plant, is a potent GABA antagonist.

  • RP 48497

    RP 48497 is a photodegradation product of Eszopiclone. Eszopiclone is used in the treatment of insomnia.

  • Cajanin

    Cajanin has potential hypolipidemic effects,possibly via up-regulating the ABCA1 protein expression,subsequently resulting in increased macrophage cholesterol efflux and RCT, it can significantly improve basal glucose uptake in HepG2 cells, its improving effect is concentration dependent, it exhibits effects stronger than that of rosiglitazone, which has been used as an antidiabetic drug.